Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Thomas

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Journal of Computer Assisted Tomography|January 1, 1986
MR imaging of the lung using liquid perfluorocarbonsS R Thomas, L C Clark, J L Ackerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patientsH R Maxon, E E Englaro, S R Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDPR C Samaratunga, S R Thomas, J D Hinnefeld, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygenL C Clark, J L Ackerman, S R Thomas, et al.
Radiology|January 1, 1978
Dose to the metaphyseal growth complexes in children undergoing 99mTc-EHDP bone scansS R Thomas, M J Gelfand, J G Kereiakes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 1998
Rhenium-188(Sn)HEDP for treatment of osseous metastasesH R Maxon, L E Schroder, L C Washburn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placeboH R Maxon, L E Schroder, V S Hertzberg, et al.
Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.
Oncogene|June 10, 2014
PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signalingS E Moody, A C Schinzel, S Singh, et al.
Radiology|July 1, 1990
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancerH R Maxon, L E Schroder, S R Thomas, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Journal of Computer Assisted Tomography|January 1, 1986
MR imaging of the lung using liquid perfluorocarbonsS R Thomas, L C Clark, J L Ackerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patientsH R Maxon, E E Englaro, S R Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDPR C Samaratunga, S R Thomas, J D Hinnefeld, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygenL C Clark, J L Ackerman, S R Thomas, et al.
Radiology|January 1, 1978
Dose to the metaphyseal growth complexes in children undergoing 99mTc-EHDP bone scansS R Thomas, M J Gelfand, J G Kereiakes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 1998
Rhenium-188(Sn)HEDP for treatment of osseous metastasesH R Maxon, L E Schroder, L C Washburn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placeboH R Maxon, L E Schroder, V S Hertzberg, et al.
Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.
Oncogene|June 10, 2014
PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signalingS E Moody, A C Schinzel, S Singh, et al.
Radiology|July 1, 1990
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancerH R Maxon, L E Schroder, S R Thomas, et al.
Pageof 17